Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
agitation
alcohol
alcohol, neurologic complications with
alcoholic withdrawal states, DT's, convulsions, etc.
amenorrhea
amphetamines
anticonvulsants
anxiety
benzodiazepine
benzodiazepine agonist
bromocriptine
Chiari Frommel syndrome
clonidine
cocaine
delirium
detoxification
drug induced neurologic disorders
drug withdrawal
empty sella syndrome
ergotamine
galactorrhea
hypothyroidism
lergotrile
menses
naltrexone
neoplasm, pituitary
neoplasm, pituitary, treatment of
opiate
oral contraceptives
phenothiazine
progressive supranuclear palsy
prolactin
prolactin, elevated
review article
seizure
seizure, treatment of
seizure, withdrawal
skull x-ray
skull x-ray, abnormal
treatment of neurologic disorder
visual field defect
zolpidem
Showing articles 200 to 250 of 488 << Previous Next >>

A Pilot Study of Oral Sumatriptan as Intermittent Prophylaxis of Menstruation-Related Migraine
Neurol 51:307-309, Newman,L.C.,et al, 1998

Inappropriate Use of Sumatriptan:Population Based Register and Interview Study
BMJ 316:1352-1353, Gaist,D.,et al, 1998

Pregnancy Outcome Following First Trimester Exposure to Sumatriptan
Neurol 51:581-583, Shuhaiber,S.,et al, 1998

Sumatriptan Injection Reduces Productivity Loss During a Migraine Attack
Arch Int Med 158:1013-1018, Cady,R.C.,et al, 1998

Cabergoline Treatment of Early Parkinson's Disease:First Yr of Trtm Comparison of Cabergoline & Levodopa
Neurol 48:363-368, Rinne,U.K.,et al, 1997

Sumatriptan Nasal Spray for Acute Treatment of Migraine, Results of Two Clin Studies
Neurol 49:1225-1230, 11931997., Ryan,R.,et al, 1997

Optimizing the Dose of Zolmitriptan (Zomig, *311C90) for the Acute Treatment of Migraine
Neurol 49:1210-1218, 11931997., Rapoport,A.M.,et al, 1997

Clinical Efficacy and Tolerability of 2. 5Mg Zolmitriptan for the Acute Treatment of Migraine
Neurol 49:1219-1225, Solomon,G.D.,et al, 1997

Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine
Neurol 49:1485-1490, Mathew,T.,et al, 1997

Characteristics and Determinants of Sumatriptan-Associated Chest Pain
Arch Neurol 54:1387-1392, Ottervanger,J.P.,et al, 1997

Lifestyle-Associated Risk Factors for Acute Brain Infarction Among Persons of Working Age
Stroke 28:26-30, Haapaniemi,H.,et al, 1997

Continuous Bromocriptine Therapy in Menstrual Migraine
Neurol 48:101-102, Herzog,A.G., 1997

Nasal Benzodiazepines for Management of Acute Childhood Seizures
Lancet 349:222-223, Wallace,S.J., 1997

Pharmacological Management of Alcohol Withdrawal
JAMA 278:144-151, Mayo-Smith,M.F., 1997

The Alcohol Withdrawal Syndrome
Lancet 349:1897-1900, Hall,W.&Zador,D., 1997

Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997

Sumatriptan for Migraine Attacks in Children:A Randomized Placebo-Controlled Study
Neurol 48:1100-1103, Hamalainen,M.L.,et al, 1997

Distinction of Idiopathic Parkinson's Dis from Multi-Syst Atrophy by Stim of Growth-Hormone Release w Clonidine
Lancet 349:1877-1881, Kimber,J.R.,et al, 1997

Safety and Efficacy of Pramipexole in Early Parkinson Disease
Parkinson Study Group, JAMA 278:125-1301997., , 1997

Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997

Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997

Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997

Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997

Use of Low-Dose Oral Contraceptives and Stroke in Young Women
Ann Int Med 127:596-603, Schwartz,S.M.,et al, 1997

Case-Control Study of Oral Contraceptives & Risk of Thromboembolic Stroke
BMJ 315:1502-1504, Heinermann,L.A.J.,et al, 1997

Double-Blind Comparison of Pramipexole & Bromocriptine Trtm with Placebo in Advanced Parkinson's Disease
Neurol 49:1060-1065, Guttman,M.,et al, 1997

Chiasmal Herniation as a Complication of Bromocriptine Therapy
J Neuro-Ophthalmol 16:252-257, Taxel,P.,et al, 1996

Restless Legs Syndrome:Clinicoetiologic Correlates
Neurol 47:1435-1441, Ondo,W.&Jankovic,J., 1996

Use of Sumatriptan in Post-Ictal Migraine Headache
Neurol 47:1104, Jacob,J.,et al, 1996

A Double-Blind Study of Subcut Dihydroergotamine vs Subcut Sumatriptan in Treat of Acute Migraine
Arch Neurol 53:180-184, Winner,P.,et al, 1996

Rizatriptan vs Sumatriptan in Acute Trmt of Migraine. Dutch/US Rizatriptan Study Group
Arch Neurol 53:1132-1137, Visser,W.H.,et al, 1996

Long-term Prognosis in Cerebral Venous Thrombosis:Follow-up of 77 Patients
Stroke 27:243-246, Preter,M.,et al, 1996

Stroke in Users of Low-Dose Oral Contraceptives
NEJM 335:8-15, 531996., Petitti,D.B.,et al, 1996

Ischaemic Stroke and Combined Oral Contraceptives:Results of an International, Multicentre, Case-Control Study
Lancet 348:498-505, Poulter,N.R.,et al, 1996

Bromocriptine and Postpartum Cerebral Angiopathy:A Causal Relationship
Neurol 46:1754-1756, Comabella,M.,et al, 1996

Cerebral Venous Sinus Thrombosis Associated with Factor V Gene Mutation
JNNP 61:204-205, Kimber,T.,et al, 1996

Antiepileptic Medication and Oral Contraceptive Interactions:A National Survey of Neurologists and Obstetricians
Neurol 46:1534-1539, Krauss,G.L.,et al, 1996

Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996

History of Migraine and Risk of Cerebral Ischaemia in Young Adults
Lancet 347:1503-1506, Carolei,A.,et al, 1996

Easy Therapeutical Management of Sumatriptan-Induced Daily Headache
Neurol 47:297-298, Gobel,H.,et al, 1996

Diagnosis and Management of Migraine
BMJ 312:1279-1283, Goadsby,P.J.&Olesen,J., 1996

A Comparison of Subcutaneous Sumatriptan and Dihydroergotamine Nasal Spray in the Acute Treatment of Migraine
Neurol 47:361-365, Touchon,J.,et al, 1996

Sumatriptan in Clinical Practice:A 2-year Review of 453 Migraine Patients
Neurol 47:46-51, Visser,W.H.,et al, 1996

Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996

Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996

Medication for Children with Attentional Disorders
Pediatrics 98:301-304, Perrin,J.,et al, 1996

New Antiepileptic Drugs
NEJM 334:1583-1590, Dichter,M.A.&Brodie,M.J., 1996

Lorazepam and Midazolam in the Intensive Care Unit:A Randomized, Prospective, Multicenter Study of Hemodynamics, Oxygen Transport, Efficacy, and Cost
Crit Care Med 24:222-228, Cernaianu A.C.,et al, 1996

Primary Prevention of Stroke
NEJM 333:1392-1400, Bronner,L.L.,et al, 1995

The Poisoned Patient with Altered Consciousness, Controversies in the Use of a"Coma Cocktail"
JAMA 274:562-569, Hoffman,R.S.&Goldfrank,L.R., 1995



Showing articles 200 to 250 of 488 << Previous Next >>